Hat mitgewirkt an:
-
Latenzzeiten bei der Diagnosestellung des Multiplen Myeloms
-
Geriatric assessments and frailty scores in multiple myeloma patients : : a needed tool for individualized treatment?
-
Choosing the right therapy for patients with relapsed/refractory multiple myeloma (RRMM) in consideration of patient-, disease- and treatment-related factors
-
Osteoprotective medication in the era of novel agents : : a european perspective on values, risks and future solutions